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Emphysema causes pulmonary hyperinflation, airway
obstruction, and increased pulmonary compliance.
Experimental evidence has demonstrated a reduction in
total lung volume after lung volume reduction surgery,
which may restore the mechanics of breathing to a more
physiologically usual state.1 Previous clinical and labo-
ratory investigation found improvements in air flow and
pulmonary compliance to occur with lung volume
reduction surgery.1-4 Although it is speculated that
greater physiologic benefit might be gained with higher
resection volumes, some physiologic parameters must
limit the extent of tolerable resection. Diffusing capac-
ity has been shown to decrease with extensive pul-
monary tissue resection in an animal model of lung vol-
ume reduction surgery.5 Changes in diffusing capacity
occurring with lung volume reduction surgery have not
been correlated with changes in air flow and pulmonary
compliance as resection volumes increase. A clear
understanding of both the physiologic benefits and the
diminishing returns associated with increasing resec-
tion volumes would facilitate optimal clinical outcome
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with lung volume reduction surgery. The purpose of
this study was to investigate the effects of progressive-
ly increasing lung resection volumes on pulmonary
compliance, air flow, and diffusing capacity in an ani-
mal model of elastase-induced emphysema.
Methods
The Institutional Animal Care and Use Committee at the
University of California, Irvine, approved this protocol. All
rabbits were cared for in accordance with the “Guide for the
Care and Use of Laboratory Animals” prepared by the
Institute of Laboratory Animal Resources and published by
the National Institutes of Health (NIH Publication No. 86-23,
revised 1985).
Animal preparation. Sixty-eight adult male New Zealand
White rabbits (2.3-4.8 kg) were anesthetized intramuscularly
with a 2:1 mixture of ketamine hydrochloride (100 mg/mL)
and xylazine (20 mg/mL) at a dose of 0.75 mL/kg. The rab-
bits were intubated with a 3-mm endotracheal tube and
received mechanical ventilation (Harvard Apparatus Dual
Phase Control Respiratory Pump–Canine, Harvard Co, South
Natick, Mass) with a tidal volume of 50 mL and a respirato-
ry rate of 30 to 40 breaths/min. One 20-gauge intravenous
catheter was placed in a marginal ear vein for vascular access.
Anesthesia was maintained with 0.3 mL of a 1:1 mixture of
ketamine hydrochloride (100 mg/mL) and xylazine (20
mg/mL) given as an intravenous bolus as needed to maintain
apnea throughout all procedures.
Induction of emphysema. Emphysema was induced in 68
rabbits that were under general anesthesia by aerosolizing
15,000 units (7.89 mL) of porcine elastase (Worthington
Biochemical Corporation, Lakewood, NJ) through the endo-
tracheal tube during approximately 1 hour. The nebulizer
(Respirgard; Marquest Medical Products, Inc, Englewood,
Colo) was connected to the inspiratory arm of the ventilator
circuit with the ventilator set to a tidal volume of zero and a
respiratory rate of 30 breaths/min. The oxygen flow through
the nebulizer was adjusted to maintain a peak airway pressure
of 20 cm H2O. An analog manometer placed at the side port
of the endotracheal tube monitored the peak airway pressure.
Pulmonary function testing. Lung function measure-
ments were obtained at baseline before induction of emphy-
sema, immediately before the operation at 4 weeks after
induction of emphysema, and 1 week after the operation.
Static respiratory system compliance, forced expiratory flow,
and diffusing capacity were measured at each interval.
Static respiratory system compliance measurement. To
measure static respiratory system pressures the anesthetized,
apneic rabbits were disconnected from the ventilator and
placed in the left decubital position. A 60-mL syringe was
attached to the end of the endotracheal tubes and the lungs
were inflated to a volume 60 mL above functional residual
capacity (FRC) 3 times to establish a constant volume histo-
ry. The lungs were allowed to passively deflate. Static respi-
ratory system pressures were measured separately at each
inflation volume of 60, 50, 40, 30, and 20 mL above FRC.
The appropriate volume was injected and the syringe was
held in place for 5 seconds while static airway pressure was
measured. The syringe was then released and the lungs were
allowed to passively deflate. Static respiratory system pres-
sures were measured with a water manometer (10AA25;
Meriam Instruments, Cleveland, Ohio) connected to the side
port of the endotracheal tube. The rabbits were returned to
mechanical ventilation after the measurements. Compliance
was calculated by dividing the sum of the FRC and inflation
volume above FRC by the measured static respiratory system
pressure at each inflation volume.
Dynamic expiratory flow measurement. The anes-
thetized rabbits were placed into a sealed acrylic box for
measurement of forced expiratory flows. The endotracheal
tube was connected to an external port through which the rab-
bits were ventilated while in the box. A pneumotachometer
and flow transducer (MP45-14; Validyne Engineering Corp,
Northridge, Calif) was connected to the external port for air
flow measurements. The box was pressurized and maintained
at 20 cm H2O pressure to simulate a forced expiratory
maneuver by the rabbits.
Volumes of 60 mL greater than FRC were injected in the
airway through the pneumotachometer with a syringe. The
syringe was disconnected from the pneumotachometer and the
rabbit was allowed to exhale the 60 mL through the pneumo-
tachometer. This expiratory maneuver was repeated 4 times
and results were averaged for each rabbit. To verify that max-
imal flows were achieved at 20 cm H2O the forced expiratory
maneuver was repeated at a higher pressure of 25 cm H2O to
demonstrate approximate equivalence of maximal flows.
The flow transducer was calibrated with a 60-mL syringe
immediately before each expiratory measurement. An ana-
log-to-digital converter (Keithley System 570; Keithley,
Cleveland, Ohio) sampling at 60 Hz was used to digitize the
pressure transducer data, which were then stored on an IBM
personal computer (IBM Corp, White Plains, NY). Flow was
converted to volume by integration across time. Forced expi-
ratory flows at 60 mL inflation were calculated from the dig-
ital data.
Single-breath carbon monoxide diffusing capacity. The
inhalation gasses consisted of 9.30% helium, 60.50% oxy-
gen, 29.05% nitrogen, 0.87% ethylene, and 0.28% carbon
monoxide labeled with oxygen 18 (Liquid Carbonics Corp,
Los Angeles, Calif). All gas concentrations were measured
continuously with an on-line mass spectrometer (MGA 1100;
Perkins-Elmer Corp, Pomona, Calif). Analog data were con-
verted to digital information with an analog-to-digital con-
verter (Keithley System 570) sampling at 20 Hz and stored on
an IBM personal computer.
The anesthetized and intubated rabbits were removed from
the ventilator and placed in a left decubital position. The sam-
pling tube of the mass spectrometer was connected to the side
port of the endotracheal tube through which the inspired and
expired gas concentrations were continuously measured. A
syringe was filled to 60 mL with inhalation gases and con-
nected to the endotracheal tube.
Five-second breath-holding carbon monoxide diffusing
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capacity (DLCO) maneuvers were performed on each rabbit.
All gas concentrations were measured continuously through
the mass spectrometer. A 60-mL portion of the inhalation gas
was insufflated into the lung through the endotracheal tube
and held for 5 seconds. A 30-mL portion of the inspired vol-
ume was then withdrawn and held to measure the gas con-
centrations at 50% of expired volume. All data were sampled
and digitized at 20 Hz.
For analysis the breath-holding time was measured from
0.5 seconds from the start of inspiration to 30 mL exhalation.
The duration of inhalation was rapid, and peak concentrations
were achieved within 1 second. The initial concentration of
carbon monoxide labeled with oxygen 18 was measured at its
plateau after gas insufflation. The final gas concentration was
measured at 30 mL exhalation. DLCO was calculated from the
standard formula and corrected to standard temperature and
pressure dry conditions. DLCO was expressed in terms of mil-
liliters of carbon monoxide that would diffuse for each differ-
ence of 1 mm Hg between alveolar partial pressure of carbon
monoxide and pulmonary blood carbon monoxide pressure.
Lung volume reduction surgery. Lung volume reduction
surgery was performed 4 weeks after elastase induction of
emphysema. The anterior chest wall of the anesthetized and
intubated rabbit was shaved and the rabbit was placed in a
supine position. Fifty-eight rabbits underwent resection of
varying quantities of lung tissue. Ten control rabbits under-
went median sternotomy and chest tube placement with no
excision of lung tissue (sham operation).
Hypothermia was prevented with a surgical warming pad.
Ringer’s lactate solution was infused through an intravenous
catheter in a marginal ear vein at a rate of 5 to 15 mL/h. The
rabbits received mechanical ventilation with the ventilator
described previously. Oxygen saturation (Ohmeda Biox 3700
Pulse Oximeter; BOC Health Care, Boulder, Colo), tidal car-
bon dioxide (Ohmeda 5200 CO2 Monitor; BOC Health Care),
and electrocardiogram (Hewlett-Packard 78353B Continuous
EKG Monitor; BioMedical Services, Andover, Mass) were
monitored continuously.
The shaved chest was prepared with povidone-iodine
(Betadine) and draped in sterile fashion. The thorax was
entered through a median sternotomy. Bilateral upper and
middle lobes were excised with a linear thoracoscopic stapler
(Endopath ELC; Ethicon Endo-Surgery, Somerville, NJ) with
3.5-mm staples. Target quantity of lung tissue removed
ranged from 0 to 5.8 g. Excised lung tissue was weighed dur-
ing the procedure to ensure the achievement of target resec-
tion amounts (Fig 1). During sham operations no lung tissue
was excised. Hemostasis was obtained and a 12F neonatal
chest tube was placed into each pleural space under direct
visualization. The 2 chest tubes were connected to 10 cm
H2O suction. The sternum was closed with interrupted 0 silk
suture and the chest wound was closed in layers with
absorbable monofilament sutures. The rabbits were awakened
from anesthesia and extubated. Any air leaks present were
mild and spontaneously sealed within the first hour after the
operation. All chest tubes were removed within 1 hour after
the operation.
Histologic preparation. Animals were killed 1 week after
the lung volume reduction operation. The lungs were removed
en bloc and inflated with formalin (20 cm H2O pressure) for
histologic preparation. Each rabbit lung was sectioned into
upper, middle, and lower lung fields. The lung sections were
prepared at 0.2 to 0.4 cm thicknesses and embedded in paraf-
fin. Slides were stained with hematoxylin-eosin and studied
by light microscopy. The histologic appearance was graded
according to the number of alveolar walls counted from an
end-terminal bronchiole toward the lung periphery. The num-
ber of walls per millimeter was noted. With this model we pre-
viously reported a statistically significant difference in the
number of alveolar walls counted per millimeter between rab-
bits treated once with 15,000 units of elastase and control rab-
bits to whom no elastase was administered.1
Statistical analysis. All compliance, expiratory flow, and
DLCO data for each rabbit were tabulated corresponding to
baseline, preoperative, and postoperative measurements. For
forced expiratory flows and diffusing capacity, comparisons
of the change from the preoperative to the postoperative mea-
surements between the 3 groups were made with analysis of
variance (Systat 7.0.1; SPSS Inc, Chicago, Ill). For compli-
ance, comparisons of postoperative values between groups
were made with analysis of variance. Pressure-volume curves
were generated for each treatment group from baseline, pre-
operative, and postoperative measurements, and a best-fit
curve was generated from a polynomial equation.
Results
The mortality rate after emphysema induction was
approximately 20%. Deaths were caused by pneumo-
thorax or pulmonary hemorrhage. Most of these deaths
occurred within the first 24 hours after elastase adminis-
tration. The surgical mortality rate was quite low com-
pared with the mortality rate obtained after the induction
of emphysema. One animal died with surgery after the
resection of 4.4 g of lung tissue, placing it among those
with the largest resection amounts. Occasionally the ani-
mals had small air leaks after the operation. Air leaks
usually abated within 1 hour after the end of the opera-
tion, at which time chest tubes were removed. The 1 sur-
gical death was of an animal with an undetected air leak,
which caused death the first night after the operation.
Fig 1. Graph shows distribution of lung tissue resected.
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For this analysis animals were divided into 3 treat-
ment groups according to the amount of lung tissue
excised. Group 1 underwent median sternotomy with
no lung tissue resected (sham operation, group 1).
Group 2 had 3 g or less of lung tissue resected. Group
3 had more than 3 g of lung tissue resected.
Compliance. Total lung capacity was calculated at
each insufflation volume above FRC (gas dilution).
Static respiratory system compliance was then calculat-
ed from the mean static respiratory system pressures at
60, 50, 40, 30, and 20 mL above FRC. With the induc-
tion of emphysema, static respiratory system compli-
ance increased in all 3 treatment groups (Fig 2). The
mean compliances (± SEM) at 60 mL above FRC for
groups 1, 2, and 3 were, respectively, 5.0 ± 0.23, 4.8 ±
0.11, and 4.9 ± 0.10 at baseline and 5.8 ± 0.29, 5.6 ±
0.11, and 5.7 ± 0.14 before the operation. After lung
volume reduction surgery static respiratory system
compliance decreased in all groups, but it did so more
in group 3, the high resection volume group (P = .000
by analysis of variance, Figs 2 through 4). After the
operation the mean compliances at 60 mL above FRC
for groups 1, 2, and 3 were, respectively, 5.7 ± 0.23, 4.9
± 0.12, and 4.2 ± 0.17 (Table I).
Forced expiratory flow. Forced expiratory air flows
were assessed at 33% of expiration (FEF33%) with 20
cm H2O body box pressure as previously described.1
The change in FEF33% increased with greater than 3 g
resection by an average of 16.5 ± 25.3 mL (Fig 5). In
contrast, the change in FEF33% decreased by 22.4 ± 8.3
mL and 13.5 ± 11.1 mL in groups 1 and 2, respectively.
Diffusing capacity. The mean DLCO values (± SEM)
for groups 1, 2, and 3 were, respectively, 0.61 ± 0.03,
0.63 ± 0.03, and 0.67 ± 0.04 at baseline and 0.59 ± 0.04,
0.62 ± 0.03, and 0.63 ± 0.03 before the operation. The
effects of lung volume reduction surgery on DLCO are
Fig 2. Graph shows change in static respiratory system compli-
ance before induction of emphysema (baseline), immediately
before lung volume reduction surgery (preop), and 1 week after
lung volume reduction surgery at time animals were killed
(postop). Ordinate represents static respiratory system compli-
ance at 60 mL inflation above mean FRC. Compliance is
expressed in milliliters per centimeter of water. Abscissa shows
3 time points at which measurements were taken. Postoperative
analysis of variance, P = .000. Total animals tested, N = 68.
Fig 3. Graph shows pressure-volume relationship of large-
volume treatment group before and after operation. Total lung
capacity is expressed in milliliters and equals insufflation
volume above mean FRC. Pressure is given as mean static
respiratory system pressure measurements in units of cen-
timeters of water. Total animals tested, N = 68.
Fig 4. Graph shows change in compliance as continuous function of amount of tissue resected with lung volume
reduction surgery; r = 0.590, P < .00001. Total animals tested, N = 68.
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shown in Figs 6 and 7 as the change in DLCO from pre-
operative to postoperative values (P = .189 by analysis
of variance). Although diffusing capacity deteriorated in
all treatment groups after the operation, it declined most
in the high resection volume group and least in the low
resection volume group. The sham operation group had
an intermediate decline in diffusing capacity. Our expe-
rience with this technique with the first 14 rabbits
demonstrated a similar pattern of change in DLCO with
lung volume reduction surgery.5 After the operation the
mean DLCO value (± SEM) for groups 1, 2, and 3 were,
respectively, 0.52 ± 0.03, 0.57 ± 0.03, and 0.51 ± 0.03.
Histologic examination. Histologic examination
confirmed the presence of mild to moderate diffuse
emphysema in each animal at necropsy. The pattern of
emphysema was centrilobular, patchy, and variable
among individual rabbits.
Discussion
Lung volume reduction surgery is a rapidly evolving,
dynamic area of research. This procedure has been pro-
posed as potential palliative treatment for end-stage
emphysema and as an alternative to lung transplanta-
tion for selected patients with end-stage emphysema.6,7
Many questions remain regarding patient selection cri-
teria and optimization of clinical outcomes. It is essen-
tial that we understand both the physiologic mecha-
nisms responsible for physiologic gain and the limiting
factors for lung volume reduction surgery.
Loss of pulmonary elasticity is central to the patho-
physiology of expiratory flow obstruction in emphyse-
ma.8 Clinically, emphysema is characterized by pul-
monary and thoracic hyperexpansion caused by a loss
of elastic recoil in the pulmonary parenchyma.
Increased static compliance and decreased expiratory
flows have been shown to occur with the development
of emphysema in this elastase-induced animal model of
pulmonary emphysema.1, 9 In this study static respira-
tory system compliance increased with the develop-
ment of emphysema in all rabbit groups. Compliance
decreased toward baseline value with lung volume
Fig 5. Graph shows change in forced expiratory flow with
lung volume reduction surgery. Ordinate represents change in
FEF33% with lung volume reduction surgery. Abscissa repre-
sents treatment group. Analysis of variance, P = .378. Group
1 (sham), n = 9; group 2 (0.4-3.0 g), n = 31; group 3, (3.1-5.8
g), n = 22.
Fig 6. Graph shows change in DLCO with lung volume reduc-
tion surgery. Ordinate represents DLCO with lung volume
reduction surgery. Abscissa represents treatment group.
Analysis of variance, P = .189. Group 1 (sham), n = 9; group
2 (0.4-3.0 g), n = 31; group 3, (3.1-5.8 g), n = 22.
Fig 7. Graph shows change in DLCO as continuous function
of amount of tissue resected with lung volume reduction
surgery; r = 0.215. P = .133. Total animals tested, N = 67.
Table I. Compliance with emphysema and lung volume
reduction surgery
Postoperative 
Baseline Preoperative (1 wk)
Sham operation 5.0 ± 0.23 5.8 ± 0.29 5.7 ± 0.23
Lung resection ≤3 g 4.8 ± 0.11 5.6 ± 0.11 4.9 ± 0.12
Lung resection >3 g 4.9 ± 0.10 5.7 ± 0.14 4.2 ± 0.17
Values are mean compliance in millimeters per centimeter of water ± SEM at
60 mL above FRC for 3 treatment groups at baseline, before the operation,
and after the operation.
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reduction surgery in proportion to the amount of lung
volume resected (Figs 2 through 4). These data suggest
that clinical improvement in elastic recoil may be pro-
portional to extent of tissue volume resection.
Lung volume reduction surgery probably improves
respiratory system compliance by increasing elastic
recoil within the lung parenchyma.3, 10 Removal of
redundant pulmonary parenchyma improves recoil
properties of the remaining parenchyma. Expiratory dri-
ving pressures increase while chest hyperexpansion is
reduced, and respiratory mechanics return to a more
physiologically usual state. Our findings suggest that
greater resection of lung tissue yields greater benefit in
elastic recoil. Patients with severe chest hyperexpansion
may benefit from more extensive lung volume resection.
With lung volume reduction surgery, expiratory flow
showed the greatest improvement in animals receiving
large volume resection. Expiratory flow decreased in
animals receiving low-volume resection. Expiratory
flow has been correlated with airway resistance.1 Re-
moval of emphysematous lung tissue may improve
radial traction of remaining lung tissue to improve con-
ductance of the airways.
It may appear counterintuitive that resection of pul-
monary parenchyma would improve the gas exchange
properties of the remaining pulmonary tissue in a disease
characterized by destruction of the pulmonary parenchy-
ma. Clinical studies have reported variable outcomes in
diffusing capacity after lung volume reduction surgery,
ranging from minimal improvement to 200% improve-
ment with respect to preoperative values.3, 4, 10, 11
An earlier report with this animal model demonstrat-
ed that DLCO improved slightly at resection volumes
smaller than 3 g and then subsequently deteriorated to
subpreoperative levels with higher resection volumes.5
The results of this investigation demonstrated a trend
toward deterioration in diffusing capacity with lung
volume reduction surgery in all treatment groups, with
contrasting improvements in spirometry and compli-
ance. Although the greatest decline in diffusing capac-
ity was seen after resection of volumes larger than 3 g,
lung compliance and respiratory flows continued to
improve with larger resections. It is likely that greater
resection of pulmonary parenchyma reduces the ability
of the lungs to transport gases. Gas diffusing capacity
is governed by the quantity of functioning pulmonary
capillaries, alveolar wall surface area and thickness,
and ventilation-perfusion matching in extreme disease
states. Resection of functioning capillaries and alveoli
along with emphysematous tissue is probably responsi-
ble for the reduction in DLCO seen in our model. It is
interesting that we saw less reduction in DLCO in the
group receiving low-volume lung volume reduction
surgery than in the rabbits undergoing sham operation.
Improvements in ventilation-perfusion mismatch are
the probable explanation for improvements in DLCO
that have been reported in some cases. In this study it
is possible that low-volume lung volume reduction
surgery palliated some of the ventilation-perfusion
mismatch and partially offset decreases in capillary bed
and alveolar wall surface. If this is true, lung volume
reduction surgery may provide greater palliation to
patients with more severe ventilation-perfusion mis-
match. A model of more severe emphysema may be
needed to definitively clarify these issues.
The findings of this study suggest that resection of
pulmonary parenchyma for mild to moderate emphyse-
ma impairs gas diffusing capacity and that this impair-
ment limits the practical extent of lung resection.
Whereas compliance shows improvements at larger
resection volumes, diffusing capacity shows diminish-
ing returns with increasing resection volumes. This
raises concerns that patients who have reduced pul-
monary vascular capacity and pulmonary hypertension
may not tolerate extensive lung volume resection.
There are a number of limitations to this study.
Histologic studies of this animal model confirm the
presence of mild to moderate diffuse emphysema.
Measurement of FRC with this animal model confirms
an increase of approximately 30%.1 However, increas-
es approaching 250% may be seen in patients with
severe chronic emphysema. Additionally, pulmonary
hypertension and pulmonary vascular disease manifes-
tations of chronic emphysema may require a longer
time to develop fully than the 4 weeks of this study.
The degree of physiologic changes may be milder in
this model than seen clinically. The response to surgi-
cal treatment in milder disease may be different from
the response in more severe disease states.
Alternatively, the results of this study could also be
interpreted to suggest that lung volume reduction
surgery may afford clinical improvement to patients
with less severe emphysema than that for which it is
currently being recommended.
Pulmonary function measurements in this study were
performed on anesthetized, paralyzed rabbits in a rest-
ing state. Cardiopulmonary physiology with exertion is
different than with rest. The greater physiologic
demands of exertion may allow resection of less tissue.
Most patients with severe emphysema suffer dyspnea
with exertion and not at rest. Diffusing capacity and
pulmonary artery pressures may be highly sensitive to
physical exertion.
Future studies should focus on identifying other
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physiologic variables that may decline with greater
lung resection with observed deterioration in diffusing
capacity. Because portions of the pulmonary capillary
bed are resected with lung volume reduction surgery, a
rise in pulmonary artery pressure may parallel declines
in diffusing capacity. Pulmonary artery pressure mea-
surements may provide useful intraoperative guidance
in optimizing resection volume.
Clinical results have been variable with lung volume
reduction surgery. The mechanisms of clinical
improvement and limitations with lung volume reduc-
tion surgery have not been well described. This study
suggests that optimal resection volumes with lung vol-
ume reduction surgery exist but may require a surgical
approach individually tailored to the clinical physio-
logic presentation once a clearer understanding of the
complex variables governing response to lung volume
reduction surgery has been attained. Compliance and
expiratory flow show maximal benefit with large lung
resection volumes. In contrast, diffusing capacity
showed less decline with lower lung resection volumes.
Depending on the clinical presentation, some patients
may benefit from larger lung resection volumes and
other patients may benefit from more conservative lung
resection volumes. Emphysema is a heterogeneous dis-
ease with a wide spectrum of presentation. Optimal
surgical outcomes will result from thoughtful evalua-
tion in the application of therapy.
R E F E R E N C E S
1. Huh J, Brenner M, Chen J, Yoong B, Gassel A, Kafie F, et al.
Changes in pulmonary physiology alter lung volume reduction
surgery in a rabbit model of emphysema. J Thorac Cardiovasc
Surg 1998:115:328-35.
2. Brenner M, Yoong B, Budd M, Kafie F, Waite T, Mukai D, et al.
The effect of lung volume reduction surgery on static compliance
and maximal flows in a rabbit model of emphysema. Chest
1996:110(4 suppl):177S.
3. Sciurba FC, Rogers RM, Keenan RJ, Slivka WA, Gorcsan J,
Ferson PF, et al. Improvement in pulmonary function and elastic
recoil after lung-reduction surgery for diffuse emphysema. N
Engl J Med 1996;334:1095-9.
4. O’Donnell DE, Webb KA, Bertley JC, Chau LK, Conlan AA.
Mechanisms of relief of exertional breathlessness following uni-
lateral bullectomy and lung volume reduction surgery in emphy-
sema. Chest 1996;110:18-27.
5. Chen JC, Brenner M, Huh J, Yoong B, Gassel A, Kafie F, et al.
Effect of lung volume reduction surgery on pulmonary diffusion
capacity in a rabbit model of emphysema. J Surg Res 1998;
78:155-60.
6. Bavaria JE, Pochettino A, Kotloff RM, Rosengard BR, Wahl PM,
Roberts JR, et al. Effect of volume reduction on lung transplant
timing and selection for chronic obstructive pulmonary disease. J
Thorac Cardiovasc Surg 1998;115:9-18.
7. McKenna RJ Jr, Brenner M, Fischel RJ, Singh N, Yoong B, Gelb
AF, et al. Patient selection criteria for lung volume reduction
surgery. J Thorac Cardiovasc Surg 1997;114:957-64.
8. Brantigan O, Mueller E, Kress MB. A surgical approach to pul-
monary emphysema. Am Rev Respir Dis 1959;80:194-202.
9. Raub JA, Mercer RR, Miller FJ, Graham JA, O’Neil JJ. Dose
response of elastase-induced emphysema in hamsters. Am Rev
Respir Dis 1982;125:432-5.
10. Gelb AF, Brenner M, McKenna RJ Jr, Zamel N, Fischel R,
Epstein JD. Lung function 12 months following emphysema
resection. Chest 1996;110:1407-15.
11. Hazelrigg S, Boley T, Henkle J, Lawyer C, Johnstone D,
Naunheim K, et al. Thoracoscopic laser bullectomy: a prospec-
tive study with three-month results. J Thorac Cardiovasc Surg
1996;112:319-26.
Discussion
Dr Joel D. Cooper (St Louis, Mo). I am interested in your
animal model. We have been extremely frustrated during the
last year trying to produce emphysema in dogs with a method
that in the literature was said to yield emphysema, namely,
inhalation of papain. We followed the published recipe, and
we have obstructive lung disease but do not have emphysema.
The papain model appears to produce a small-airway disease.
You clearly produced a nice model of emphysema. What is
the pattern of emphysema that you get with your model? In
the histologic section you showed very nice alveolar destruc-
tion. I have 2 questions.
First, do you think that I could do the same thing in dogs
with repeated elastase? Certainly the papain model has not
worked. Second, in terms of clinical implication it clearly
depends on the homogeneity or the heterogeneity of the
model. In the clinical volume reduction situation, of course,
one hopes to be removing volume without removing diffusing
capacity, as it were, because there is no blood flow to the por-
tion of the lung that is removed. Is your model relevant in that
way; namely, do you produce more upper lobe disease than
lower lobe disease or do you have a homogeneous pattern?
Dr Chen. With respect to the pattern of emphysema, this is
a heterogeneous model. We did initial experiments, as report-
ed in the Journal,1 illustrating that our pattern of emphysema
was that of predominantly upper lobe. That is, with the tech-
nique we used the elastase appears to be selectively localized
to the upper lobe region. This is a central lobar emphysema
model, as graded by various histologic sectioning through
different parts of the lung.
With respect to your question about papain in dogs, I am
aware of some other groups that are trying to do this. We have
not experimented with papain in rabbits. As to whether a dog
model would be better than a rabbit model, I would only be
speculating. The reason that we chose to work with rabbits
was that the duration of the experiments was such that we
were actually housing these rabbits for 6 weeks, and it may
be that in fact we will need to house them even longer to
develop a severe model of emphysema as opposed to a mod-
erate model. As one can imagine, the costs of these experi-
ments are not trivial.
Dr Larry R. Kaiser (Philadelphia, Pa). Comment a little
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bit more on your model. What is the natural history of the
model? Do these animals die of emphysema? I mean, do they
ultimately go ahead and die if you follow them up long
enough? Also comment, if you will, on multiple inhalations of
elastase versus the single inhalation of elastase with respect to
the severity of the emphysema that is produced.
Dr Chen. In terms of the natural history, we have no data.
Again, these animals were operated on after 4 weeks and at 1
week after the operation we killed them, so I cannot tell you
about the natural history. This is an interesting question,
though, and something that we can certainly look at.
In terms of multiple inductions versus single inductions, we
are actually trying this. We unfortunately do not have enough
data yet to give you any definitive conclusions. Perhaps next
year we will present these data. In terms of multiple induc-
tions, however, early results at least suggest that more severe
emphysema is induced according to histologic profile. With
respect to pulmonary function, there appears to be some
increase in absolute lung volumes—that is, total lung capacity
and residual volume—but I am not sure that this is going to
turn out to be significant.
Dr David J. Sugarbaker (Boston, Mass). Could you com-
ment on what might be a deficiency in the model? In human
beings, of course, the respiratory embarrassment that ulti-
mately results from chronic emphysema results in some
chronic and rather static changes in chest wall mechanics and
diaphragmatic activity. Could you comment on how this
might affect your model, in the sense that you really have a
4-week effect and then you are really looking at some physi-
ologic parameters?
Dr Chen. I am glad that you asked. The rabbit model is
somewhat different from emphysema in human beings in that
the rabbit chest wall—that is, the musculoskeletal component
of it—is quite flexible, so that in fact we have done experi-
ments to try to quantify the amount of elasticity of the chest
wall and determine how that contributes into the elastic recoil
of our calculations. So this will be somewhat different than
that in a human individual.
The other important difference is that the rabbit is essen-
tially a 4-legged animal, whereas human beings are not.
Rabbits spend most of their lives prone, whereas human
beings spend most of their lives upright. Certainly there are
going to be some changes in pulmonary mechanics because
of that. Nevertheless, we have found that our model produces
predominantly upper lobe disease, which reflect the pattern
seen in human beings.
With respect to other chronic changes, we are further eval-
uating pulmonary vascular changes in our rabbit model of
emphysema. We hope to be able to correlate our laboratory
findings with clinical findings in the near future.
